 The session was held April 28, 2011, at the Scientific Education Research Institute (SERI), Thornton, CO. Participants in the session included: Dr. Ron Sokol, Director, Colorado Clinical and Translational Sciences Institute (CCTSI) - keynote speaker; Fred Mitchell, CEO, Beacon Biotechnology; Dr. Larry Gold, Chairman and Chief Science Officer, SomaLogic; David Brunel, CEO, Biodesix; and Dr. Pauline Gee, Chief Science Officer, BodySync. Vicki Jenings, Director of Business Relations, Fitzsimons Redevelopment Authority, moderated the session.
The session was held April 28, 2011, at the Scientific Education Research Institute (SERI), Thornton, CO. Participants in the session included: Dr. Ron Sokol, Director, Colorado Clinical and Translational Sciences Institute (CCTSI) - keynote speaker; Fred Mitchell, CEO, Beacon Biotechnology; Dr. Larry Gold, Chairman and Chief Science Officer, SomaLogic; David Brunel, CEO, Biodesix; and Dr. Pauline Gee, Chief Science Officer, BodySync. Vicki Jenings, Director of Business Relations, Fitzsimons Redevelopment Authority, moderated the session.Video links:
Dr. Ron Sokol, Director, Colorado Clinical and Translational Sciences Institute (CCTSI) - first of four parts: http://youtu.be/X8iiwUAzXH0?hd=1
Fred Mitchell, CEO, Beacon Biotechnology - first of two parts: http://youtu.be/VnEjbe1mHAY?hd=1
David Brunel, CEO, Biodesix - first of two parts: http://youtu.be/Ea2ot7Q8e4M?hd=1
Panel Discussion - first of two parts: http://youtu.be/DIEfNg9-a98?hd=1
 
 
 
 
 
 


No comments:
Post a Comment